Seegene Arab League
상단으로
اتصل بنا

أخبار المنتج يمكنك التحقق من أحدث معلومات المنتج

  • Obtained CE-IVD marking for Seeplex® MTB ACE Detection

    Seeplex® MTB ACE Detection Detection of M. tuberculosis (MTB) Seegene's Seeplex® MTB ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB ACE Detection

  • Obtained CE-IVD marking for Seeplex® MTB Nested ACE Detection

    Detection of M. tuberculosis (MTB) in various specimens Seegene's Seeplex® MTB Nested ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB Nested ACE Detection

  • Obtained CE-IVD marking for Seeplex® MTB/BCG ACE Detection

    Seeplex® MTB/BCG ACE Detection Discrimination of MTB from M. bovis BCG Seegene's Seeplex® MTB/BCG ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB/BCG ACE Detection

  • Launched Seeplex® VRE ACE Detection

    Detection of vanA & vanB genes which cause vancomycin-resistanceSeeplex® VRE ACE Detection detects the vanA and vanB genes which cause vancomycin-resistance in enterococci isolated from stool culture in a single test. The Seeplex® VRE ACE Detection detects the vanA and vanB genes which cause vancomycin-resistance in enterococci isolated from stool culture in a single test.Enterococci are normally indigenous bacteria found in the GI tract and female genitals, but recently they were recognized as major pathogens causing urinary tract infections and sepsis by nosocomial infection. Vancomycin, which is used in the treatment of enterococci infection, is a drug that has an antibacterial effect by forming a complex with the D-alanyl-D-alanine terminal of the peptidoglycan precursor to block transglycosylation and transpeptidation during the synthesis of the cell wall of Gram-positive cocci. However, vancomycin-resistant enterococci (VRE) tend to multiply rapidly due to the high frequency and continuous use of vancomycin. The Seeplex® VRE ACE Detection is a PCR method that incorporates DPO technology with high sensitivity and specificity, and is a product that can test for the vancomycin- resistant vanA gene and the vanB gene of enterococci in one test.

    Mar 03, 2008｜ Seeplex® VRE ACE Detection

  • Launched Seeplex® RV5 ACE Screening

    Seeplex® RV5 ACE Screening Rapid screening of the most prevalent respiratory virusesSeeplex® RV5 ACE Screening is designed to screen the most prevalent respiratory viruses. The conventional methods (culture and IFA, etc.) to detect respiratory viruses take several days or do not have enough sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's Respiratory Virus Detection is outstanding in terms of sensitivity and specificity by applying DPO™ technology and detects multiple respiratory viruses by Multiplex RT-PCR

    Mar 01, 2008｜ Seeplex® RV5 ACE Screening

  • Launched Seeplex® RV12 ACE Detection

    Seeplex® RV12 ACE Detection Simultaneously detecting 12 major respiratory virusesSeeplex® RV 12 ACE Detection is designed to detect major respiratory viruses. The conventional methods (culture and IFA, etc.) to detect respiratory viruses take several days or do not have enough sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's Respiratory Virus Detection is outstanding in terms of sensitivity and specificity by applying DPO™ technology and detects multiple respiratory viruses by Multiplex RT-PCR.

    Feb 01, 2008｜ Seeplex® RV12 ACE Detection

  • Launched Seeplex® STD/HPV Test

    Seeplex® STD/HPV Test Screening of the most common STD and HPV high-risk/low-risk typesSeeplex® HPV/STD4 ACE Screening is designed to simultaneously screen for the most common STD and HPV high-risk/low-risk types. Seeplex® HPV/STD4 ACE Screening detects most common STD-causing pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae and detects 16 HPV high-risk types and 5 HPV low-risk types, separately. It is a very useful diagnostic method for prevention and timely treatment of STD and cervical cancer because two most frequently detected STD-causing pathogens and cervical cancer-causing HPV high-risk types can be simultaneously detected in a single tube.

    Nov 01, 2007｜ Seeplex® STD/HPV Test

  • Obtained CE-IVD marking for Seeplex® RV7 Detection

    Simultaneously detecting major respiratory viruses Seegene's Seeplex® RV7 Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Sep 28, 2007｜ Seeplex® RV7 Detection

1112131415